Evidence map›Paper›PMID 35612774›Full record

ArticleGeroScience2022

Association of cerebral microvascular dysfunction and white matter injury in Alzheimer's disease.

Zsolt Bagi, Christopher D Kroenke, Katie Anne Fopiano, Yanna Tian, Jessica A Filosa, Larry S Sherman, Eric B Larson, C Dirk Keene, Kiera Degener O'Brien, Philip A Adeniyi and 1 more

Open access · greenAbstract read
In one paragraph

Article in GeroScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Role of endocrine PACAP in age-related diseases.Frontiers in endocrinology · 2023
    Review
  17. Article
  18. Article
  19. Editorial: The role of astrocyte in vascular aging.Frontiers in aging neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Zsolt BagiDepartment of Physiology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA. zbagi@augusta.edu.ORCID 0000-0001-8755-2980
Christopher D KroenkeAdvanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA.
Katie Anne FopianoDepartment of Physiology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA.
Yanna TianDepartment of Physiology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA.
Jessica A FilosaDepartment of Physiology, Medical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA, 30912, USA.
Larry S ShermanDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Eric B LarsonKaiser Permanente Health Research Institute, Seattle, WA, USA.
C Dirk KeeneDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.
Kiera Degener O'BrienDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
Philip A AdeniyiDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
Stephen A BackDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA. backs@ohsu.edu.
Augusta University · USOregon Health & Science University · USOregon National Primate Research Center · USKaiser Permanente Washington Health Research Institute · USUniversity of Washington · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
Oligodendrocyte Progenitors and Mechanisms of Human Vascular White Matter InjuryR01NS105984 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BACK, STEPHEN ARTHUR · 2019 to 2023
$3.7M
Oligodendrocyte Progenitors and Hyaluronan-mediated Mechanisms of Human Vascular White Matter InjuryRF1AG065406 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BACK, STEPHEN ARTHUR · 2020 to 2020
$2.9M
Multi-Disciplinary Training Program in the Mechanisms of Cardiometabolic DiseaseT32HL155011 · NHLBI · AUGUSTA UNIVERSITY · PI STEPP, DAVID W, SULLIVAN, JENNIFER C · 2021 to 2025
$1.1M
Oligodendrocyte Progenitors and Hyaluronan-mediated Mechanisms of Human Vascular White Matter InjuryR01AG065406 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BACK, STEPHEN ARTHUR · 2024 to 2024
$667k
American Heart Association-American Stroke Association 20PRE35211126 - YANNA TIANNHLBI NIH HHS T32 HL155011NIA NIH HHS P30 AG066509NIA NIH HHS R01 AG065406NIA NIH HHS RF1 AG065406NIH HHS P51 OD011092NINDS NIH HHS R01 NS105984
6 · The paper itself

Abstract

Patients with Alzheimer's disease (AD) often have cerebral white matter (WM) hyperintensities on MRI and microinfarcts of presumed microvascular origin pathologically. Here, we determined if vasodilator dysfunction of WM-penetrating arterioles is associated with pathologically defined WM injury and disturbances in quantitative MRI-defined WM integrity in patients with mixed microvascular and AD pathology. We analyzed tissues from 28 serially collected human brains from research donors diagnosed with varying degrees of AD neuropathologic change (ADNC) with or without cerebral microinfarcts (mVBI). WM-penetrating and pial surface arteriolar responses to the endothelium-dependent agonist bradykinin were quantified ex vivo with videomicroscopy. Vascular endothelial nitric oxide synthase (eNOS) and NAD(P)H-oxidase (Nox1, 2 and 4 isoforms) expression were measured with quantitative PCR. Glial fibrillary acidic protein (GFAP)-labeled astrocytes were quantified by unbiased stereological approaches in regions adjacent to the sites of WM-penetrating vessel collection. Post-mortem diffusion tensor imaging (DTI) was used to measure mean apparent diffusion coefficient (ADC) and fractional anisotropy (FA), quantitative indices of WM integrity. In contrast to pial surface arterioles, white matter-penetrating arterioles from donors diagnosed with high ADNC and mVBI exhibited a significantly reduced dilation in response to bradykinin when compared to the other groups. Expression of eNOS was reduced, whereas Nox1 expression was increased in WM arterioles in AD and mVBI cases. WM astrocyte density was increased in AD and mVBI, which correlated with a reduced vasodilation in WM arterioles. Moreover, in cases with low ADNC, bradykinin-induced WM arteriole dilation correlated with lower ADC and higher FA values. Comorbid ADNC and mVBI appear to synergistically interact to selectively impair bradykinin-induced vasodilation in WM-penetrating arterioles, which may be related to reduced nitric oxide- and excess reactive oxygen species-mediated vascular endothelial dysfunction. WM arteriole vasodilator dysfunction is associated with WM injury, as supported by reactive astrogliosis and MRI-defined disrupted WM microstructural integrity.

Indexed as

Alzheimer DiseaseWhite MatterBradykininDiffusion Tensor ImagingHumansVasodilator AgentsBradykininVasodilator AgentsAgingAlzheimer’s diseaseAstrocyteDilationMicrovascularMRIWhite matter

Identifiers

PMID35612774
PMCPMC9617002
OpenAlexW4281493288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.